Glucose targets during heart-lung bypass in older adults with diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests different blood sugar targets during heart surgery that uses a heart-lung machine for older adults with diabetes, to see which range may reduce complications. It focuses on people having combined heart procedures, like bypass plus valve surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older
- You have type 2 diabetes and have been taking glucose-lowering medication for at least 3 months
- You are scheduled for elective heart surgery that involves a heart-lung machine and combines two or more procedures (like bypass plus valve repair)
- You do not have severe liver disease, do not need dialysis, and have no severe disability from a prior stroke
- Your recent blood sugar control (HbA1c) is 10% or less
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares different strategies for keeping a specific blood pressure level during heart-lung bypass surgery. It may help reduce complications by finding the safest blood pressure target during the operation.
This study looks at how the body handles carbohydrates after eating in people who have had gastric bypass surgery, with or without post-surgery hypoglycemia (low blood sugar). The goal is to understand why some people get low blood sugar after meals and how to better manage it.
This study looks at how well-controlled blood sugar (measured by HbA1c) affects brain oxygen levels during urologic surgery and how it impacts recovery afterward. It compares diabetic patients to non-diabetic patients to understand the role of blood sugar control in surgical outcomes.
This study tests whether drinking a carbohydrate drink before gastrointestinal surgery is safe and helpful for people with type 2 diabetes. It uses a continuous glucose monitor to track blood sugar levels around surgery.
This study compares two ways to restore blood flow to the heart—stent placement (PCI) versus bypass surgery (CABG)—in people with diabetes and significant multi-vessel coronary artery disease. It looks at outcomes using both standard heart tests and additional imaging/functional measurements to guide the best revascularization strategy.
This trial tests a smart insulin pump system (hybrid closed-loop) to control blood sugar in people with type 2 diabetes who need surgery and will receive nutrition through a vein. It aims to prevent high and low blood sugar during and after surgery.
Hear when a new Glycemic Management During CPB in Elderly Diabetic Cardiac Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.